Medicare Enrolled
Dr. James Tsai, M.D.
Hematology & Oncology · Hemet, CA
Practice pattern: Mixed Practice
— Diverse clinical practice across multiple procedure types
Low-engagement
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Tsai from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Tsai?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Tsai
Dr. James Tsai is a hematology & oncology specialist in Hemet, CA, with 20 years of NPI registration. Based on federal Medicare data, Dr. Tsai performed 7,567 Medicare services across 772 unique beneficiaries.
Between the years covered by Open Payments, Dr. Tsai received a total of $4,097 from 49 pharmaceutical and/or device companies across 198 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in hematology & oncology. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Tsai is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 20 years in practice
▲ Top 30% volume in CA
$4,097 industry payments
Medicare Practice Summary
Medicare Utilization ↗7,567
Medicare services
Top 30% in CA for hematology & oncology
772
Unique beneficiaries
$23
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~378 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Dexamethasone injection (steroid) An injection of dexamethasone sodium phosphate, a corticosteroid medication, administered in a dose of 1 milligram. |
1,948 | $0 | $1 |
| Anti-nausea injection (ondansetron/Zofran) | 1,863 | $0 | $1 |
| Telephone medical discussion, 21-30 minutes A telephone conversation with a physician lasting between 21 and 30 minutes. This code covers the time spent discussing medical matters over the phone. |
592 | $91 | $229 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
531 | $99 | $229 |
| Iron dextran injection, 50 mg An injection containing 50 mg of iron dextran administered to the patient. |
486 | $13 | $26 |
| Normal saline infusion, 250 cc Administration of 250 cubic centimeters of normal saline solution into a vein. This procedure involves the intravenous delivery of a sterile saltwater fluid. |
382 | $1 | $20 |
| Drug injection, under skin or into muscle A procedure involving the administration of a medication or substance via injection into the subcutaneous tissue or muscle. |
267 | $11 | $48 |
| Vitamin B-12 injection An injection of vitamin B-12 (cyanocobalamin) with a dose of up to 1000 mcg. |
191 | $1 | $10 |
| Additional sequential IV infusion, 1 hour or less This code represents an additional intravenous infusion administered sequentially to a primary infusion. It covers the administration time of one hour or less. |
186 | $24 | $70 |
| Additional hour of intravenous chemotherapy This code represents the administration of chemotherapy medication into a vein for each additional hour beyond the initial period. |
177 | $24 | $66 |
| Intravenous chemotherapy infusion, 1 hour or less Administration of chemotherapy medication directly into a vein. The procedure takes one hour or less to complete. |
176 | $111 | $313 |
| Additional hour of intravenous hydration This code represents each additional hour of intravenous fluid administration beyond the initial hour. It is used to bill for extended hydration therapy. |
175 | $11 | $32 |
| Intravenous infusion, 1 hour or less Administration of medication or fluid directly into a vein for therapeutic, preventive, or diagnostic purposes. The procedure lasts one hour or less. |
170 | $52 | $155 |
| Additional hour of intravenous infusion This code represents each additional hour of intravenous infusion beyond the initial hour for therapy, prevention, or diagnosis. |
151 | $17 | $46 |
| Intravenous injection of additional new drug or substance Administration of an additional new medication or substance directly into a vein. |
90 | $13 | $48 |
| Diphenhydramine injection, up to 50 mg An injection of diphenhydramine hydrochloride, an antihistamine medication, administered in a dose of up to 50 milligrams. |
79 | $1 | $2 |
| Venipuncture for blood collection A procedure to draw blood from a vein for medical testing or analysis. |
50 | $75 | $220 |
| New patient office visit, complex (60-74 min) | 29 | $162 | $432 |
| New patient office visit (45-59 min) An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter. |
24 | $125 | $344 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
14.1% high complexity
67.4% medium
18.5% routine
Industry Payment Transparency
Open Payments through 2024 ↗$4,097
Total received (2018-2024)
Avg $585/year across 7 years
Top 47% in CA for hematology & oncology
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
49
Companies
198
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$3,556 (86.8%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$542 (13.2%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$280
2023
$322
2022
$428
2021
$492
2020
$428
2019
$1,219
2018
$929
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
Takeda Pharmaceuticals U.S.A., Inc.
$60
ABBVIE INC.
$32
Novartis Pharmaceuticals Corporation
$30
PFIZER INC.
$27
Janssen Biotech, Inc.
$27
SpringWorks Therapeutics, Inc.
$26
Genentech USA, Inc.
$23
Daiichi Sankyo Inc.
$20
ARRAY BIOPHARMA INC
$17
Acrotech Biopharma Inc.
$17
Top 3 companies account for 43.6% of 2024 payments
All-time payments by company (2018-2024) ›
Novartis Pharmaceuticals Corporation
$365
Janssen Biotech, Inc.
$292
E.R. Squibb & Sons, L.L.C.
$290
Takeda Pharmaceuticals U.S.A., Inc.
$289
PFIZER INC.
$288
Amgen Inc.
$250
Celgene Corporation
$180
Merck Sharp & Dohme Corporation
$178
AstraZeneca Pharmaceuticals LP
$153
Bayer HealthCare Pharmaceuticals Inc.
$151
Teva Pharmaceuticals USA, Inc.
$113
Gilead Sciences, Inc.
$109
SANOFI-AVENTIS U.S. LLC
$100
Taiho Oncology, Inc.
$92
Pharmacyclics LLC, An AbbVie Company
$91
Daiichi Sankyo Inc.
$85
AbbVie Inc.
$78
Genentech USA, Inc.
$70
ARRAY BIOPHARMA INC
$62
GENZYME CORPORATION
$62
EMD Serono, Inc.
$60
Incyte Corporation
$55
BeiGene USA, Inc.
$53
Pharmacyclics LLC, an AbbVie Company
$50
Kite Pharma, Inc.
$49
Epizyme, Inc.,
$45
Foundation Medicine, Inc.
$37
ABBVIE INC.
$32
Bayer Healthcare Pharmaceuticals Inc.
$28
Lexicon Pharmaceuticals, Inc.
$28
TESARO, Inc.
$26
SpringWorks Therapeutics, Inc.
$26
EISAI INC.
$26
Sun Pharmaceutical Industries Inc.
$22
GlaxoSmithKline, LLC.
$22
Eisai Inc.
$22
Myovant Sciences Inc.
$22
PUMA BIOTECHNOLOGY, INC.
$22
Seattle Genetics, Inc.
$20
TherapeuticsMD, Inc.
$19
AbbVie, Inc.
$19
West Therapeutics Development, LLC
$18
Acrotech Biopharma Inc.
$17
MorphoSys, US Inc.
$17
Puma Biotechnology, Inc.
$17
Karyopharm Therapeutics Inc.
$13
Helsinn Therapeutics (U.S.), Inc.
$12
Exelixis Inc.
$11
Clovis Oncology, Inc.
$11
Top 3 companies account for 23.1% of all-time payments
Associated products mentioned in payments ›
ADCETRIS · AKYNZEO · ALUNBRIG · Abraxane · Avastin · BELEODAQ · BENDEKA · BLENREP · BOSULIF · BRAFTOVI · BRUKINSA · Bavencio · Blincyto · Cabometyx · Creon · DALVANCE · DARZALEX · ELIQUIS · ELITEK · EMPLICITI · EPKINLY · ERLEADA · Enhertu · Erleada · FOUNDATIONONE · FRUZAQLA · Fabhalta · GAZYVA · IBRANCE · IMBRUVICA · IMFINZI · IMVEXXY · INFLECTRA · INJECTAFER · INLYTA · Imbruvica · JADENU · JAKAFI · JEVTANA · KEYTRUDA · KISQALI · Kyprolis · LENVIMA · Lazanda · Lenvima · Lonsurf · MONJUVI · MYLOTARG · NERLYNX · Nerlynx · Neulasta · Nexavar · Nplate · Nubeqa · ODOMZO (sonidegib) capsules · OGSIVEO · ONUREG · OPDIVO · ORGOVYX · OXBRYTA · PLUVICTO · PROMACTA · Perjeta · Phesgo · Pomalyst · REBLOZYL · RUXIENCE · RYDAPT · Revlimid · Rubraca · SANDOSTATIN LAR · Stivarga · TABRECTA · TAGRISSO · TASIGNA · TAZVERIK · VELCADE · VENCLEXTA · Vectibix · XALKORI · XGEVA · XPOVIO · XTANDI · Xermelo · Xofigo · Yescarta · ZEJULA
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Most payments (87%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.
Geographic Context
Hematology & oncology specialists within 10 mi
4
Per 100K population
0.2
County median income
$89,672
Nearest hospital
HEMET GLOBAL MEDICAL CENTER
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Tsai is a mixed practice specialist, with above-average Medicare volume (top 30% in CA), with low-engagement industry engagement, with 20 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Tsai experienced with dexamethasone injection (steroid)?
Based on Medicare claims data, Dr. Tsai performed 1,948 dexamethasone injection (steroid) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Tsai receive payments from pharmaceutical companies?
Yes. Dr. Tsai received a total of $4,097 from 49 companies across 198 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Tsai's costs compare to other hematology & oncology specialists in Hemet?
Dr. Tsai's average Medicare payment per service is $23. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Tsai) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Same specialty & city
Hematology & Oncology Specialists in Hemet
Browse hematology & oncology specialists in Hemet ranked by procedure volume and transparency data.
Highest volume
Top Hematology & Oncology Specialists in CA
Hematology & oncology specialists ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Hematology & Oncology Specialists in CA
Which CA hematology & oncology specialists receive the most from drug and device companies.
By company
Novartis Pharmaceuticals Corporation Payments to Doctors
See all physicians who received payments from Novartis Pharmaceuticals Corporation.
By company
Janssen Biotech, Inc. Payments to Doctors
See all physicians who received payments from Janssen Biotech, Inc.
By company
E.R. Squibb & Sons, L.L.C. Payments to Doctors
See all physicians who received payments from E.R. Squibb & Sons, L.L.C.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology